The landscape for drug design has changed drastically over the past few years: private and public partnerships are changing how research is being done, researchers are using 3D model systems in hopes of improving clinical outcomes, and emerging target classes are changing traditional concepts of the drug discovery process.
The European Pharma Summit 2017 will bring together presentations on innovative findings in drug discovery across three tracks:
- 12th Drug Design & Medicinal Chemistry
- 5th GPCR Targeted Screening
- 3rd Kinase Inhibitors in Drug Discovery
Key members of the Domainex team will be at the event, and look forward to seeing you there. Senior Business Development Manager, George Buckley will be joined by Principal Research Leader (Medicinal Chemistry), Gary Newton and Senior Assay biologist, Daniel Hothersall. They would love to find out more about your projects and discuss how Domainex can support your drug discovery programmes.